These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 22902503)

  • 41. T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.
    Szodoray P; Stanford SM; Molberg Ø; Munthe LA; Bottini N; Nakken B
    J Allergy Clin Immunol; 2016 Sep; 138(3):839-851.e8. PubMed ID: 27056269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.
    Sabouri Z; Schofield P; Horikawa K; Spierings E; Kipling D; Randall KL; Langley D; Roome B; Vazquez-Lombardi R; Rouet R; Hermes J; Chan TD; Brink R; Dunn-Walters DK; Christ D; Goodnow CC
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2567-75. PubMed ID: 24821781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A B cell receptor with two Igalpha cytoplasmic domains supports development of mature but anergic B cells.
    Reichlin A; Gazumyan A; Nagaoka H; Kirsch KH; Kraus M; Rajewsky K; Nussenzweig MC
    J Exp Med; 2004 Mar; 199(6):855-65. PubMed ID: 15024049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice.
    Wang YH; Diamond B
    J Clin Invest; 2008 Aug; 118(8):2896-907. PubMed ID: 18636122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.
    Zinkernagel RM; Pircher HP; Ohashi P; Oehen S; Odermatt B; Mak T; Arnheiter H; Bürki K; Hengartner H
    Immunol Rev; 1991 Aug; 122():133-71. PubMed ID: 1937540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Checkpoints in lymphocyte development and autoimmune disease.
    von Boehmer H; Melchers F
    Nat Immunol; 2010 Jan; 11(1):14-20. PubMed ID: 20016505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary Immune Responses and Affinity Maturation Are Controlled by IgD.
    Amendt T; Ayoubi OE; Linder AT; Allies G; Young M; Setz CS; Jumaa H
    Front Immunol; 2021; 12():709240. PubMed ID: 34434193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line.
    Man RY; Onodera T; Komatsu E; Tsubata T
    PLoS One; 2010 Jan; 5(1):e8815. PubMed ID: 20098688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
    Dörner T; Szelinski F; Lino AC; Lipsky PE
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32675278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo.
    Nguyen TG; Morris JM
    Immunol Lett; 2014 Sep; 161(1):157-64. PubMed ID: 24954638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
    Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
    Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritis.
    Lyubchenko T; Zerbe GO
    PLoS One; 2014; 9(7):e102128. PubMed ID: 25057856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1.
    Agazio A; Cimons J; Shotts KM; Guo K; Santiago ML; Pelanda R; Torres RM
    Front Immunol; 2020; 11():1565. PubMed ID: 32849530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pten controls B-cell responsiveness and germinal center reaction by regulating the expression of IgD BCR.
    Setz CS; Khadour A; Renna V; Iype J; Gentner E; He X; Datta M; Young M; Nitschke L; Wienands J; Maity PC; Reth M; Jumaa H
    EMBO J; 2019 Jun; 38(11):. PubMed ID: 31015337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clonal deletion and clonal anergy as the mechanism of self-tolerance induction].
    Ota H; Yanagida H; Dobashi H; Ishida H
    Nihon Rinsho; 1997 Jun; 55(6):1331-6. PubMed ID: 9200914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B cell tolerance to epidermal ribonuclear-associated neo-autoantigen in vivo.
    Degn SE; Alicot E; Carroll MC
    Clin Exp Immunol; 2018 Feb; 191(2):151-165. PubMed ID: 28984923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of B-cell tolerance.
    Jacquemin MG; Vanzieleghem B; Saint-Remy JM
    Adv Exp Med Biol; 2001; 489():99-108. PubMed ID: 11554595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.